Medicare Advantage medical policy

Policy updates

Regence Medicare Advantage and its affiliated Plans use medical policies as guidelines for coverage decisions within the member’s written benefits. Below are summaries of recent changes to the Medicare Advantage medical policy manual. We have included the section and policy number for your convenience.

The complete Medicare Medical Policy Manual with detailed policies are available online at https://www.regence.com/provider/library/policies-guidelines/medical-policy/ma-medical-policy.

Last updated: April 1, 2025

Policy name

Summary of policy or change

Effective date

Section and policy number

New policy to address electromagnetic navigation bronchoscopy.

July 1, 2025

Surgery #M-179

Expanding post-service review of rotary air ambulance.

July 1, 2025

Utilization Management #M-13

Added Medicare guidance for disposable negative pressure wound therapy devices and care.

April 1, 2025

Durable Medical Equipment #M-42

New policy for mechanical residual limb volume management systems (e.g., RevoFit) for upper extremity prostheses.

April 1, 2025

Durable Medical Equipment #M-98

Revised to align with the 2025 Q2 code update and updated Medicare guidance.

April 1, 2025

Genetic Testing #M-64

Revised to align with the 2025 Q2 code update and updated Medicare guidance.

April 1, 2025

Genetic Testing #M-83

Revised to align with the 2025 Q2 code update.

April 1, 2025

Medicine #M-149

Adding new LCD (L39812) and Article (A59697) addressing minimally invasive sacroiliac joint fusion.

April 1, 2025

Surgery #M-193

Updated criteria to use commercial policy for TYMS testing in the health plan service area.

March 1, 2025

Laboratory #M-64

Added additional guidance for wheelchair accessories.

February 1, 2025

Durable Medical Equipment #M-37

Added new NCD addressing implanted pulmonary artery pressure sensors for heart failure management.

February 1, 2025

Medicine #M-33

Removed retired LCD guidance.

February 1, 2025

Medicine #M-49

Added new Noridian LCD, Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers.

February 1, 2025

Medicine #M-170

New policy addresses the use of ablation of peripheral nerves to treat pain.

February 1, 2025

Surgery #M-236

Updated policy to address concurrent optical and electromagnetic stimulation for wound healing.

January 1, 2025

Durable Medical Equipment #M-83

Updated the policy in alignment with the 2025 Q1 annual code update and latest Medicare guidance.

January 1, 2025

Genetic Testing #M-64

Updated the policy in alignment with the 2025 Q1 annual code update and latest Medicare guidance.

January 1, 2025

Genetic Testing #M-83

Updated the policy in alignment with the 2025 Q1 annual code update.

January 1, 2025

Medicine #M-149

  • Changed policy title; policy was previously titled Radiofrequency Ablation of the Renal Sympathetic Nerves as a Treatment for Uncontrolled Hypertension.
  • Policy updated to address ultrasound renal denervation for the treatment of hypertension.

January 1, 2025

Surgery #M-235

New policy addresses screening laboratory testing in asymptomatic individuals.

December 1, 2024

Laboratory #M-80

NCD 110.23 criteria for allogeneic HSCT for myelodysplastic syndrome (MDS) has been expanded.

December 1, 2024

Transplant #M-45

Updated policy to remove retired Medicare guidance and add new billing and coding guidance.

November 1, 2024

Durable Medical Equipment #M-78

Updated policy to address only dual chamber leadless pacemakers.

November 1, 2024

Surgery #M-217

Recently archived policies

Policy name

Archive date

Medicare Manual section and policy #

Radioembolization, Transarterial Embolization (TAE), and Transarterial Chemoembolization (TACE)

November 1, 2024

Medicine #M-140